tiprankstipranks
Advertisement
Advertisement

DE:ABL Stock Latest News

Abbott Buy Rating Reaffirmed as Analyst Sees Accelerating 2027 Earnings; $120 Price Target Maintained on Libre Duo Growth Potential
RatingsAbbott Buy Rating Reaffirmed as Analyst Sees Accelerating 2027 Earnings; $120 Price Target Maintained on Libre Duo Growth Potential
1d ago
ABT
Abbott announces new data on DKA for people with Type 1, Type 2 diabetes
PremiumThe Fly
Abbott announces new data on DKA for people with Type 1, Type 2 diabetes
2d ago
ABT
MiniMed announces expanded ketone sensor agreement with Abbott
PremiumThe Fly
MiniMed announces expanded ketone sensor agreement with Abbott
6d ago
ABT
MMED
Abbott Laboratories: Buy Rating Reaffirmed on Improving 2026 Growth Outlook and Margin Expansion Potential, with Price Target Trimmed to $113
PremiumRatings
Abbott Laboratories: Buy Rating Reaffirmed on Improving 2026 Growth Outlook and Margin Expansion Potential, with Price Target Trimmed to $113
8d ago
ABT
Abbott secures CE Mark for Libre Duo, Libre Duo 10 Day
PremiumThe Fly
Abbott secures CE Mark for Libre Duo, Libre Duo 10 Day
13d ago
ABT
Abbott: ACS releases updated CRC guidelines reaffirm Cologuard, Cologuard Plus
PremiumThe FlyAbbott: ACS releases updated CRC guidelines reaffirm Cologuard, Cologuard Plus
13d ago
ABT
Jefferies medical supplies analyst holds analyst/industry conference call
Premium
The Fly
Jefferies medical supplies analyst holds analyst/industry conference call
1M ago
ABT
AI Models Split on Abbott Laboratories (ABT) as Fundamentals Clash With Technical and Valuation Concerns
Premium
AI Analyst Ratings
AI Models Split on Abbott Laboratories (ABT) as Fundamentals Clash With Technical and Valuation Concerns
1M ago
ABT
Abbott removed from US Conviction List at Goldman Sachs
PremiumThe Fly
Abbott removed from US Conviction List at Goldman Sachs
1M ago
ABT
FDA releases results from ‘largest-ever’ testing of infant formula in the U.S.
PremiumThe Fly
FDA releases results from ‘largest-ever’ testing of infant formula in the U.S.
1M ago
ABT
Abbott receives FDA clearance and CE Mark for Ultreon imaging platform
PremiumThe Fly
Abbott receives FDA clearance and CE Mark for Ultreon imaging platform
1M ago
ABT
Abbott Expands Board and Enhances Equity Incentive Programs
PremiumCompany Announcements
Abbott Expands Board and Enhances Equity Incentive Programs
1M ago
8K
ABT
Abbott announces new late-breaking data from four trials on PFA, CSP portfolios
PremiumThe FlyAbbott announces new late-breaking data from four trials on PFA, CSP portfolios
1M ago
ABT
Abbott downgraded to Neutral from Outperform at Daiwa
Premium
The Fly
Abbott downgraded to Neutral from Outperform at Daiwa
2M ago
ABT
Abbott price target lowered to $143 from $144 at Barclays
Premium
The Fly
Abbott price target lowered to $143 from $144 at Barclays
2M ago
ABT
Abbott Reaches Preliminary Settlement in Derivative Governance Case
PremiumCompany Announcements
Abbott Reaches Preliminary Settlement in Derivative Governance Case
2M ago
8K
ABT
Abbott says data at AACR demonstrate advancements in Cancerguard test
PremiumThe Fly
Abbott says data at AACR demonstrate advancements in Cancerguard test
2M ago
ABT
Abbott price target lowered to $130 from $135 at RBC Capital
PremiumThe Fly
Abbott price target lowered to $130 from $135 at RBC Capital
2M ago
ABT
Abbott price target lowered to $115 from $132 at Oppenheimer
PremiumThe Fly
Abbott price target lowered to $115 from $132 at Oppenheimer
2M ago
ABT
Abbott price target lowered to $115 from $135 at Piper Sandler
PremiumThe FlyAbbott price target lowered to $115 from $135 at Piper Sandler
2M ago
ABT
Abbott price target lowered to $120 from $145 at Benchmark
Premium
The Fly
Abbott price target lowered to $120 from $145 at Benchmark
2M ago
ABT
Abbott price target lowered to $120 from $145 at Stifel
Premium
The Fly
Abbott price target lowered to $120 from $145 at Stifel
2M ago
ABT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >